Home » Topics » BioWorld Science

BioWorld Science
RSS

FINCH 2 study of filgotinib in rheumatoid arthritis meets primary endpoint

Sep. 12, 2018

Innate Pharma initiates phase I study of IPH-5401 with durvalumab in solid tumors

Sep. 12, 2018

Janssen Pharmaceutica presents OGA inhibitors

Sep. 12, 2018

Dual sHE inhibitor/PPAR-gamma agonist shows benefits to treat metabolic syndrome and diabetes in rat

Sep. 12, 2018

Prelude Therapeutics identifies new PRMT5 inhibitors

Sep. 12, 2018

Innate Tumor Immunity synthesizes new NLRP3 agonists for cancer

Sep. 12, 2018

RQx Pharmaceuticals and Genentech present antibacterial compounds

Sep. 12, 2018

SuPAR predicts chronic kidney disease progression in Black Americans

Sep. 12, 2018

Phase III study of Zerbaxa in HABP and VABP meets primary endpoints

Sep. 12, 2018

Trevena patents new delta-opioid receptor modulators

Sep. 12, 2018

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...